Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSC) Assets Average (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Assets Average for 6 consecutive years, with $4.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Assets Average fell 28.13% to $4.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.4 million, a 28.13% decrease, with the full-year FY2024 number at $4.2 million, down 3.35% from a year prior.
  • Assets Average was $4.4 million for Q3 2025 at Ensysce Biosciences, down from $5.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $14.4 million in Q1 2022 to a low of $3.0 million in Q4 2023.
  • A 5-year average of $7.0 million and a median of $6.1 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: plummeted 70.44% in 2021, then surged 152.78% in 2024.
  • Ensysce Biosciences' Assets Average stood at $13.1 million in 2021, then tumbled by 45.76% to $7.1 million in 2022, then tumbled by 58.19% to $3.0 million in 2023, then skyrocketed by 152.78% to $7.5 million in 2024, then tumbled by 41.57% to $4.4 million in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Assets Average are $4.4 million (Q3 2025), $5.1 million (Q2 2025), and $5.1 million (Q1 2025).